Substance Abuse Testing

State lawmakers have been very busy tackling cannabis issues in 2023, and the year is not over.  As of this publication, the adult use of cannabis is permitted in 23 states. Thirty-seven states have authorized the medical use of cannabis.

With increased public opinion on marijuana legalization, the increased use of marijuana and other illicit substances; the challenges and effects of the COVID-19 pandemic, and managing remote workforces, employers are being challenged with creating safe, healthy, and effective work environments amid an ongoing recruitment and retention crisis. Some employers may look to their substance abuse policy to see if they can make any changes to potentially create a competitive advantage. Employers should be cautioned that the U.S.

The New York Department of Labor released additional guidance in response to the wave of questions related to the adult-use of cannabis and the Marijuana Regulation and Taxation Act (“MRTA”). This guidance is intended to address some of the most common situations or questions in the workplace. Please note that this guidance does not address the medical use of cannabis.

Discrimination Prohibited

As of June 18, 2021, as this could change at any time, 37 states allow the medical use of marijuana, and 18 states permit the adult use of marijuana.[1] Many employers, and undoubtedly multi-state employers, are struggling with new rules that impact their operations. What do these new rules mean for workplace drug testing programs?  Should employers continue testing for marijuana? – can they?

A year after the pandemic, the 25th Health Care Compliance Association (HCCA) Compliance Institute took place virtually this past week. As the healthcare industry adapts to the new normal, HCCA’s conference provides an opportunity for compliance professionals to learn about the latest developments and priorities from regulators.

A survey from the Current Consulting Group (CCG) reports that since the start of the pandemic in 2020, 21% of employers have reported a drop of 61% or more in the number of drug tests that they perform on employees. There are combined factors in play, including high unemployment rates, but the majority of the decline resulted from concern about workplace drug testing safety and COVID-19 precautions.

Workplace drug testing has been around for more than forty years in the U.S.  At the start, drug testing was all about compliance with federal rules and has since evolved with state-specific laws and case laws that employers also need to follow. The primary goal of these rules is to maintain safety in our workplaces.

On December 4^th, 2020, the House of Representatives approved the MORE Act (Marijuana Opportunity and Expungement Act), a bill that would end the federal prohibition of marijuana in the United States. In the first significant Congressional action relating to marijuana since the original passage of marijuana prohibition back in 1937, lawmakers passed the historic Bill by a vote of 228-164. 

Positivity rates for employment drug testing reached a 16-year high in 2019, according to recent data collected and reported by Quest Diagnostics[1]. The overall positivity rate in the combined U.S.

On May 21, Virginia Governor Ralph Northam signed legislation that decriminalizes marijuana possession, joining a majority of states that have ceased treating the drug as a criminal offense. Here’s what employers in Virginia need to know about these changes once they go into effect on July 1.